MedTrace Logo

A Survey on the Under-treatment of hypercholeSterolemia (EPHESUS Trial)

NCT02608645 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 6000

Last updated 2015-11-20

No results posted yet for this study

Summary

In this study, within the secondary prevention group patients ( diabetes mellitus, coronary artery disease, peripheral artery disease, who have had events atherosclerotic cerebrovascular ) , statin use requirement , patients compliance and reaching target LDL-cholesterol levels (according to European guidelines ) will be evaluated.

Conditions

  • Hyperlipidemias

Sponsors & Collaborators

  • Muğla Sıtkı Koçman University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2016-09-30
Completion
2016-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02608645 on ClinicalTrials.gov